Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-10-30
2011-11-08
Minnifield, Nita M (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C424S185100, C424S234100, C424S263100, C424S278100, C530S300000, C530S350000
Reexamination Certificate
active
08052975
ABSTRACT:
Compounds and methods for the diagnosis and treatment of Chlamydial infection are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of aChlamydiaantigen and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided, together with antibodies directed against such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Chlamydial infection in patients and in biological samples.
REFERENCES:
patent: 4118469 (1978-10-01), Caldwell et al.
patent: 4497863 (1985-02-01), Armstrong et al.
patent: 4497899 (1985-02-01), Armstrong et al.
patent: 4497900 (1985-02-01), Abram et al.
patent: 5166053 (1992-11-01), Huguenel et al.
patent: 5318892 (1994-06-01), Watanabe et al.
patent: 5539084 (1996-07-01), Geysen
patent: 5629167 (1997-05-01), Ratti
patent: 5725863 (1998-03-01), Daniels et al.
patent: 5725963 (1998-03-01), Daniels et al.
patent: 5750110 (1998-05-01), Prieels et al.
patent: 5785973 (1998-07-01), Bixler et al.
patent: 5869608 (1999-02-01), Caldwell et al.
patent: 6166177 (2000-12-01), Probst et al.
patent: 6432916 (2002-08-01), Probst et al.
patent: 6447779 (2002-09-01), Probst et al.
patent: 6448234 (2002-09-01), Fling
patent: 6555115 (2003-04-01), Probst et al.
patent: 6565856 (2003-05-01), Skeiky et al.
patent: 6899880 (2005-05-01), Stephens et al.
patent: 6919187 (2005-07-01), Bhatia et al.
patent: 7041490 (2006-05-01), Griffais et al.
patent: 7101963 (2006-09-01), Griffais et al.
patent: 7105171 (2006-09-01), Stephens et al.
patent: 7253275 (2007-08-01), Stephens et al.
patent: 7361353 (2008-04-01), Grandi et al.
patent: 7384638 (2008-06-01), Bhatia et al.
patent: 7459524 (2008-12-01), Jackson et al.
patent: 7462357 (2008-12-01), Bhatia et al.
patent: 7534445 (2009-05-01), Jackson et al.
patent: 7537772 (2009-05-01), Jackson
patent: 7575913 (2009-08-01), Griffais et al.
patent: 7655246 (2010-02-01), Jackson et al.
patent: 7662391 (2010-02-01), Murdin et al.
patent: 7731980 (2010-06-01), Jackson
patent: 7803388 (2010-09-01), Jackson
patent: 2002/0061848 (2002-05-01), Bhatia et al.
patent: 2002/0146776 (2002-10-01), Bhatia et al.
patent: 2003/0175700 (2003-09-01), Bhatia et al.
patent: 2004/0029129 (2004-02-01), Wang et al.
patent: 2004/0131625 (2004-07-01), Berthet et al.
patent: 2004/0137007 (2004-07-01), Bhatia et al.
patent: 2004/0234536 (2004-11-01), Bhatia et al.
patent: 2005/0065106 (2005-03-01), Murdin et al.
patent: 2005/0084499 (2005-04-01), Bhatia et al.
patent: 2005/0106162 (2005-05-01), Grandi et al.
patent: 2005/0239160 (2005-10-01), Shaw et al.
patent: 2005/0281847 (2005-12-01), Berthet et al.
patent: 2006/0034871 (2006-02-01), Grandi et al.
patent: 2006/0216308 (2006-09-01), Grandi et al.
patent: 2006/0234260 (2006-10-01), Griffais et al.
patent: 2008/0124338 (2008-05-01), Li et al.
patent: 2008/0181918 (2008-07-01), Bhatia et al.
patent: 2008/0213264 (2008-09-01), Bhatia et al.
patent: 2008/0299142 (2008-12-01), Bhatia et al.
patent: 2008/0317772 (2008-12-01), Bhatia et al.
patent: 2009/0022755 (2009-01-01), Barth et al.
patent: 2009/0028887 (2009-01-01), Bhatia et al.
patent: 2009/0035296 (2009-02-01), Bhatia et al.
patent: 2009/0047283 (2009-02-01), Bhatia et al.
patent: 2009/0098165 (2009-04-01), Arulanandam et al.
patent: 2010/0172927 (2010-07-01), Alderson et al.
patent: 2010/0297164 (2010-11-01), Grandi et al.
patent: 192 033 (1986-08-01), None
patent: 348725 (1990-01-01), None
patent: 784 059 (1997-07-01), None
patent: 11-123078 (1999-05-01), None
patent: 2002531129-A41 (2002-09-01), None
patent: 2003515343-A41 (2003-05-01), None
patent: 2004513622-A41 (2004-05-01), None
patent: 2004527480 (2004-09-01), None
patent: 2005511076-A31 (2005-04-01), None
patent: 1020017000165-A67 (2001-06-01), None
patent: 1020027007135-A67 (2002-06-01), None
patent: 1020037000885-A67 (2003-01-01), None
patent: WO 94/06827 (1994-03-01), None
patent: WO 96/31236 (1996-10-01), None
patent: WO 97/06263 (1997-02-01), None
patent: WO 98/02546 (1998-01-01), None
patent: WO 98/10789 (1998-03-01), None
patent: WO 98/28005 (1998-07-01), None
patent: WO 99/17741 (1999-04-01), None
patent: WO 99/27105 (1999-06-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 99/51748 (1999-10-01), None
patent: WO 00/26239 (2000-05-01), None
patent: WO 00/27994 (2000-05-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 00/37494 (2000-06-01), None
patent: WO 00/46359 (2000-08-01), None
patent: WO 00/55326 (2000-09-01), None
patent: WO 00/66739 (2000-11-01), None
patent: WO 01/21804 (2001-03-01), None
patent: WO 01/21811 (2001-03-01), None
patent: WO 01/23604 (2001-04-01), None
patent: WO 01/35992 (2001-05-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 01/40757 (2001-06-01), None
patent: WO 01/46224 (2001-06-01), None
patent: WO 01/81379 (2001-11-01), None
patent: WO 01/81379 (2001-11-01), None
patent: WO 02/02606 (2002-01-01), None
patent: WO 02/08267 (2002-01-01), None
patent: WO 02/062380 (2002-08-01), None
patent: WO 02/077183 (2002-10-01), None
patent: WO 02/079244 (2002-10-01), None
patent: WO 01/85972 (2002-11-01), None
patent: WO 03/041560 (2003-05-01), None
patent: WO 03/049762 (2003-06-01), None
patent: WO 03/049762-A62 (2003-06-01), None
patent: WO 2005/002619 (2005-01-01), None
patent: WO 2006/045308 (2006-05-01), None
patent: WO 2006/104890 (2006-10-01), None
patent: WO 2006/138004 (2006-12-01), None
Read et al, Nucleic Acid Research, 2000, 28/6:1397-1406.
Barth et al, General Meeting ASM, 2003, vol. 103, p. D-179 abstract only.
Jen et al, General Meeting ASM, col. 101, p. 343, #E-67 abstract only.
Thomson et al, Genome Research, 2008, 18:161-171.
Carlson et al, Infection and Immunity, 2005, 73/10:6407-6418.
Stephens et al, Science, Oct. 23, 1998, 282:754-759.
Pannekoek et al, Drugs of TOday, 2006, 42/Suppl. A:65-73.
Schnoor, JAVMA, Dec. 1, 1989, 195/11:1548-1561.
Brunham et al, Infectious Agents and Disease, 1994, 3:218-233.
Mygind et al, FEMS Microbiology Letters, 2000, 186:163-169.
Baehr et al, PNAS, 1988, 85:4000-4004.
Batteiger et al, Infection and Immunity, 1996, 64/2:542-547.
Igietseme et al, Infection and Immunity, 2000, 68/12:6798-6806.
Gervassi et al, J. Immunology, 2004, 173:6905-6913.
Hickey et al, Current Molecular Medicine, 2005, 5:599-605.
Fling et al, PNAS, 2001, 98/3:1160-1165.
Stagg, Molecular Medicine Today, Apr. 1998, pp. 166-173.
Maclean et al, Can. J. Microbiol., 1988, 34:141-147.
Pal et al, Infection and Immunity, Aug. 1997, 65/8:3361-3369.
Su et al, Vaccine, 1995, 13/11:1023-1032.
Campos et al, Invest. Ophthalmol. Vis. Sci., Jul. 1995, 36/8:1477-1491 abstract only.
Gupta et al, Vaccine, 1995, 13/14:1263-1276.
Allen, J.E. et al., “An intermolecular mechanism of T cell halp for the production of antibodies to the bacterial pathogen,Chlamydia trachomatis,” Eur. J. Immunol. 23: 1169-1172, 1993.
Attwood, T.K, (2000), “Genomics: The Babel of Bioinformatics,” Science vol. 290, 471-473.
Baldridge et al., “Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529,” J. Endotoxin Research 2002; 8(6); 453-8. PubMed Abstract Only, PMID: 12697089.
Bixler et al, In: Synthetic Vaccines, editor Ruth Arnon, 1987, pp. 39-71.
Bowie et al, Science, Mar. 16, 1990,247:1306-1310.
Brunham et al. L (2005) “Immunology of Chlamydia Infection: Iimplications for aChlamydia trachomatisvaccine” Nature Reviews. Immunology, vol. 5, No. 2, 149-161.
Burgess et al, JCB, 1990, 111:2129-2138.
Chakrabarti et al., “Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques,” Molecular and Cellular Biology 5(12):3403-3409, Dec. 1985.
Chothia, C. et al., “The relation between the divergence of sequence and structure in proteins,” The EMBO Journal 5(4):823-826, 1986.
Conlan, J.W. et al., “Isolation of recombinant fragme
Bhatia Ajay
Probst Peter
Skeiky Yasir A. W.
Corixa Corporation
Minnifield Nita M
Seed IP Law Group PLLC
LandOfFree
Compounds and methods for treatment and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for treatment and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for treatment and diagnosis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282527